Press Release Q1 (Apr-Jun) 2025-26
Press Release Q2 (Jul-Sep) 2025-26
Press Release Q1 (Apr-Jun) 2024-25
Press Release Q3 (Oct-Dec) 2024-25
Press Release Q2 (Jul-Sep) 2024-25
Press Release Q4 (Jan-Mar) 2024-25
Press Release Q2 (Jul-Sep) 2023-24
Press Release Q3 (Oct-Dec) 2023-24
Press Release Q1 (Apr-Jun) 2023-24
Press Release Q4 (Jan-Mar) 2023-24
Press Release Q1 (Apr-Jun) 2022-23
Press Release Q3 (Oct-Dec) 2022-23
Ajanta Pharma awarded Best Managed Companies 2022 by Deloitte
Press Release Q4 (Jan-Mar) 2022-23
Press Release Q2 (Jul-Sep) 2022-23
Ajanta contributes Rs. 1 cr. to Maharashtra CM Relief Fund
Press Release Q2 (Jul-Sep) 2021-22
Press Release Buy back 2021
Press Release Q4 (Jan-Mar) 2021-22
Press Release Q3 (Oct-Dec) 2021-22
Press Release Q1 (Apr-Jun) 2021-22
Press release on resignation of Director
Eletriptan Hydrobromide Launch in US
US FDA approval for Entacapone Tablets
Clonidine Hydrochloride Extended Release Tablets Approval & Launch